Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study.
Jones DEJ, Wetten A, Barron-Millar B, Ogle L, Mells G, Flack S, Sandford R, Kirby J, Palmer J, Brotherston S, Jopson L, Brain J, Smith GR, Rushton S, Jones R, Rushbrook S, Thorburn D, Ryder SD, Hirschfield G; UK-PBC Research Consortium; Dyson JK. Jones DEJ, et al. Among authors: ogle l. EBioMedicine. 2022 Jun;80:104068. doi: 10.1016/j.ebiom.2022.104068. Epub 2022 May 21. EBioMedicine. 2022. PMID: 35609437 Free PMC article.
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.
Barron-Millar B, Ogle L, Mells G, Flack S, Badrock J, Sandford R, Kirby J, Palmer J, Jopson L, Brain J, Smith GR, Rushton S, Hegade VS, Jones R, Rushbrook S, Thorburn D, Ryder S, Hirschfield G; UK-PBC Research Consortium; Dyson JK, Jones DEJ. Barron-Millar B, et al. Among authors: ogle l. Hepatology. 2021 Dec;74(6):3269-3283. doi: 10.1002/hep.32011. Epub 2021 Nov 2. Hepatology. 2021. PMID: 34129689
Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?
Wetten A, Ogle L, Mells G, Hegade VS, Jopson L, Corrigan M, Palmer J, Johansson M, Bäckström T, Doverskog M, Jones DEJ, Dyson JK. Wetten A, et al. Among authors: ogle l. Can J Gastroenterol Hepatol. 2022 Dec 6;2022:3618090. doi: 10.1155/2022/3618090. eCollection 2022. Can J Gastroenterol Hepatol. 2022. PMID: 36523650 Free PMC article.
Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
Margetts J, Ogle LF, Chan SL, Chan AWH, Chan KCA, Jamieson D, Willoughby CE, Mann DA, Wilson CL, Manas DM, Yeo W, Reeves HL. Margetts J, et al. Among authors: ogle lf. Br J Cancer. 2018 Jan;118(2):248-257. doi: 10.1038/bjc.2017.386. Epub 2017 Nov 9. Br J Cancer. 2018. PMID: 29123264 Free PMC article.
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival.
Cornell L, Munck JM, Alsinet C, Villanueva A, Ogle L, Willoughby CE, Televantou D, Thomas HD, Jackson J, Burt AD, Newell D, Rose J, Manas DM, Shapiro GI, Curtin NJ, Reeves HL. Cornell L, et al. Among authors: ogle l. Clin Cancer Res. 2015 Feb 15;21(4):925-33. doi: 10.1158/1078-0432.CCR-14-0842. Epub 2014 Dec 5. Clin Cancer Res. 2015. PMID: 25480831 Free PMC article.
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.
Dent BM, Ogle LF, O'Donnell RL, Hayes N, Malik U, Curtin NJ, Boddy AV, Plummer ER, Edmondson RJ, Reeves HL, May FE, Jamieson D. Dent BM, et al. Among authors: ogle lf. Int J Cancer. 2016 Jan 1;138(1):206-16. doi: 10.1002/ijc.29680. Epub 2015 Aug 19. Int J Cancer. 2016. PMID: 26178530 Free PMC article.
16 results